Patient studies: RESULTS

Of the 1415 patients treated, follow-up was completed in 1241, a response rate of 87.7%. Of those responding, 1157 patients said that the treatment had been successful (93 .2%) and 84 said that it had been unsuccessful (6.8%); Follow-up period 5-24 months.